相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms
Luca Arcaini et al.
BLOOD (2012)
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation
Enrico Tiacci et al.
BLOOD (2012)
Current treatment strategies in chronic myeloid leukemia
Francois Guilhot et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Phosphatidylinositide-3-Kinase Inhibitors: Addressing Questions of Isoform Selectivity and Pharmacodynamic/Predictive Biomarkers in Early Clinical Trials
Paul A. Clarke et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
David Marin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: A possible role for 14-3-3 theta/tau and tBID?
Victoria C. Hodgkinson et al.
JOURNAL OF PROTEOMICS (2012)
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson et al.
NATURE MEDICINE (2012)
Cancer biomarkers: selecting the right drug for the right patient
Gary J. Kelloff et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
Gunter von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
BRCA1-IRIS Overexpression Promotes Formation of Aggressive Breast Cancers
Yoshiko Shimizu et al.
PLOS ONE (2012)
Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation
Frank S. Ong et al.
PHARMACOGENOMICS (2012)
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer
Qing Cheng et al.
BREAST CANCER RESEARCH (2012)
An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer
Agusti Barnadas et al.
ADVANCES IN THERAPY (2011)
Targeting BRAF for patients with melanoma
H-T Arkenau et al.
BRITISH JOURNAL OF CANCER (2011)
High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies
Elaine M. Boyd et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Laboratory methods for KRAS mutation analysis
Steven M. Anderson
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
Manfred Schmitt et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Integrating biomarkers in clinical trials
Marc Buyse et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Breast Cancer 2 Gene expression profiling in breast cancer: classification, prognostication, and prediction
Jorge S. Reis-Filho et al.
LANCET (2011)
Predictive biomarkers: a paradigm shift towards personalized cancer medicine
Nicholas B. La Thangue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Integrating predictive biomarkers and classifiers into oncology clinical development programmes
Robert A. Beckman et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Microgranular variant of acute promyelocytic leukemia with normal conventional cytogenetics, negative PML/RARA FISH and positive PML/RARA transcripts by RT-PCR
Catherine Lewis et al.
CANCER GENETICS (2011)
History of Acute Promyelocytic Leukemia: A Tale of Endless Revolution
Francesco Lo-Coco et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2011)
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
Richa Tiwary et al.
BREAST CANCER RESEARCH (2011)
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
Mari Mino-Kenudson et al.
CLINICAL CANCER RESEARCH (2010)
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
Federico Cappuzzo et al.
LANCET ONCOLOGY (2010)
Emerging companion diagnostics for cancer drugs
Jocelyn August
NATURE REVIEWS DRUG DISCOVERY (2010)
Personalized medicine in oncology: the future is now
Richard L. Schilsky
NATURE REVIEWS DRUG DISCOVERY (2010)
Melanoma - An Unlikely Poster Child for Personalized Cancer Therapy
Keiran S. M. Smalley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia
Letizia Foroni et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
Maria Paola Martelli et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy
David Grimwade et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Hereditary breast cancer: Part II. Management of hereditary breast cancer: Implications of molecular genetics and pathology
Edibaldo Silva et al.
BREAST JOURNAL (2008)
Hereditary breast cancer: Part I. Diagnosing hereditary breast cancer syndromes
Henry T. Lynch et al.
BREAST JOURNAL (2008)
Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
Kengo Takeuchi et al.
CLINICAL CANCER RESEARCH (2008)
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
Grazia Arpino et al.
ENDOCRINE REVIEWS (2008)
Hereditary breast cancer: new genetic developments, new therapeutic avenues
Philippe M. Campeau et al.
HUMAN GENETICS (2008)
Variation of breast cancer risk among BRCA1/2 carriers
Colin B. Begg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
Kentaro Inamura et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Second-line treatment of advanced non-small cell lung cancer
Cesare Gridelli et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Costs of cancer care in the USA: a descriptive review
K. Robin Yabroff et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
Thomas M. Suter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Patient time costs associated with cancer care
K. Robin Yabroff et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Trends in abnormal cancer screening results in the United States of America
K. Robin } Yabroff et al.
JOURNAL OF MEDICAL SCREENING (2007)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
Chronic myeloid leukemia:: Diagnosis and treatment
Alfonso Quintas-Cardama et al.
MAYO CLINIC PROCEEDINGS (2006)
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
Timothy Hughes et al.
BLOOD (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer
T Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
Y Nagai et al.
CANCER RESEARCH (2005)
Targeting the DNA repair defect of BRCA tumours
N Turner et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development
JW Park et al.
CLINICAL CANCER RESEARCH (2004)
Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia
A Reiter et al.
ACTA HAEMATOLOGICA (2004)
Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3
N Villamor et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
The story of chronic myeloid leukaemia
CG Geary
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
